Well Told Grants

Federal grant programs / Cancer Biology Research

Cancer Biology Research in Tennessee

Cancer Biology Research (93.396) awarded $117 million to recipients in Tennessee in 52 grants from fiscal 2021 to 2025, 2.7% of the program's national total. St Jude Children's Research Hospital Inc received the most, $46.4 million.

By year

Grants under this program to recipients in Tennessee
Fiscal yearAwardsAmount
FY 202140$23.0 million
FY 202237$21.6 million
FY 202339$25.4 million
FY 202436$23.4 million
FY 202535$24.0 million

Recipients in Tennessee

Every recipient named in the data, fiscal 2021 to 2025
RecipientTypeAwardsAmount
St Jude Children's Research Hospital IncNonprofits16$46.4 million
Vanderbilt University Medical CenterNonprofits19$43.0 million
Vanderbilt University Medical CenterColleges and universities13$20.8 million
University of TennesseeColleges and universities2$6.2 million
East Tennessee State UniversityColleges and universities1$521,828
University of TennesseeColleges and universities1$458,595

Counted by the recipient's location. A recipient based in Tennessee may carry out the work elsewhere.

Open opportunities under this program

See all 34 on the program page

Questions people ask

How much Cancer Biology Research money goes to Tennessee?

$117 million from fiscal 2021 to 2025, across 52 awards. Tennessee ranks 10th of 50 states and territories for this program.

Who receives Cancer Biology Research money in Tennessee?

The largest recipient is St Jude Children's Research Hospital Inc, with $46.4 million in 16 awards. Next are Vanderbilt University Medical Center and Vanderbilt University Medical Center.

Can organizations in Tennessee apply now?

Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.

Cancer Biology Research in other states

Other large programs in Tennessee

All federal grants in Tennessee

Amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.